IMCR
Immunocore Holdings plc
NASDAQ · Healthcare · Biotechnology · GB
$36.13
−3.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 822.23x
- P/S forward
- 3.92x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.43x
- Price / sales
- 4.61x
- Price / cash flow
- -33.03x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 3.51x
- EV / EBITDA
- 87.30x
- EV / EBIT
- -80.97x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026